NESS-040-C-5

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNESS-040-C-5
Drug Alias NameCB1/CB2 agonists (CeNeRx)CB1/CB2 agonists (CeNeRx)NESS-040-C-5
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB1 receptor agonistsCannabinoid CB2 receptor agonists
TargetsCannabinoid CB1 receptorCannabinoid CB2 receptor
Therapy Area/IndicationsOcular inflammationPainGlaucoma +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmaness Neuroscience
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmaness NeuroscienceCenerx Biopharma Inc
Active IndicationsN/A
Inactive IndicationsOcular inflammationPainGlaucoma +[5] 

Other Information

ATC CodeN/A
Related LinksN/A